MSCA DN dIscOverNET

Despite significant investments of resources in the battle against cancer, we are currently still unable to achieve long-term disease control for patients with neuroendocrine tumors (NET).


The Marie Sklodowska-Curie Action Doctoral Network (MSCA DN) dIscOverNET project will leverage the impactful preclinical immunotherapy research that is currently shaping the field of immunotherapy to systematically adapt and optimize next-generation immune-driven strategies for NET, aiming to unlock its efficacy through modulation of the tumor immune microenvironment (TIME). By bringing together interdisciplinary and intersectoral experts, dIscOverNET aims to induce durable anti-tumor responses.

Ten research partners and nine industry partners bring expertise, ensuring reciprocal intersectoral and interdisciplinary transfer of knowledge between all dIscOverNET consortium members. Each provides secondment placements, co-supervision, and access to tools and workflows for fifteen Doctoral Candidates (DC) that academic labs alone cannot offer.

Through a comprehensive, multidisciplinary training program aligned with European doctoral training principles, the DCs will be equipped to take on leading roles in European industry, academia, or government. This multifaceted training program has been carefully curated by the dIscOverNET partners to fill gaps in existing training programs while complementing with the local doctoral programs and the skills acquired by training through research. It was designed to equip young researchers with strong academic foundations, a comprehensive set of transferable skills and with international, interdisciplinary, and intersectoral exposure in order for them to become future key leaders, capable of bringing next-generation immune oncology to NET patients.